ADVFN US – Market Content Editor
-
SpaceX shares face fresh pressure as lockup expiration approaches (SPCX)
SpaceX (NASDAQ:SPCX) shares have slipped below their initial public offering price, raising concerns that the stock could face additional volatility as insider lockup restrictions begin to expire in the coming weeks. The stock fell to an intraday low of $132.15 on Wednesday before recovering to close at $135.27. Since reaching record highs shortly after its…
-
Nvidia expands AI and robotics collaboration with leading Japanese manufacturers (NVDA)
Nvidia (NASDAQ:NVDA) has announced new partnerships with several Japanese industrial companies, including Fanuc and Yaskawa Electric, as it seeks to accelerate the adoption of artificial intelligence and robotics across the manufacturing sector. Nvidia deepens its presence in Japan Speaking at a media event in Tokyo, Nvidia Chief Executive Jensen Huang outlined the company’s vision for…
-
GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS)
GH Research (NASDAQ:GHRS) shares climbed around 12% in premarket trading on Thursday after reports that Eli Lilly (NYSE:LLY) is in discussions to acquire psychedelic drug developer Atai Life Sciences (NASDAQ:ATAI), a development that sparked renewed investor interest across the sector. Potential acquisition lifts sentiment across psychedelic drug developers The reported takeover talks sent Atai shares…
-
Baidu advances Hong Kong dual primary listing plans, shares climb (BIDU)
Baidu (NASDAQ:BIDU) shares gained around 4% in premarket trading after the Chinese technology company announced plans to convert its Hong Kong listing into a dual primary listing, a move aimed at strengthening its presence in both Asian and US capital markets. Board approves listing conversion The company’s board of directors has approved a proposal to…
-
AtaiBeckley shares soar on reports of potential Eli Lilly takeover talks (ATAI)
AtaiBeckley (NASDAQ:ATAI) shares jumped as much as 53% in premarket trading on Thursday after reports emerged that Eli Lilly (NYSE:LLY) is in discussions to acquire the psychedelic drug developer. Potential deal would broaden Lilly’s neuroscience portfolio According to BMO Capital Markets analyst Evan David Seigerman, an acquisition of AtaiBeckley would strengthen Eli Lilly’s presence in…
-
Gold declines further as rising oil prices cloud the Federal Reserve outlook
Gold prices extended their losses on Thursday as investors shifted their attention from softer US inflation figures to the inflationary risks associated with higher oil prices, increasing expectations that the Federal Reserve will maintain a cautious approach to monetary policy. At 04:42 ET (08:42 GMT), spot gold (XAU/USD) was down 0.7% at US$4,032.37 an ounce,…
-
Oil prices ease after recent rally as Iran tensions keep supply concerns in focus
Oil prices moved slightly lower on Thursday, pausing after three consecutive sessions of gains, as traders continued to evaluate the impact of the conflict between the United States and Iran on global energy supplies and shipping routes through the Strait of Hormuz. By 04:38 ET (08:38 GMT), Brent crude for September delivery had fallen 0.4%…
-
US markets steady as TSMC delivers record profit and investors await key economic data: Dow Jones, S&P, Nasdaq, Wall Street Futures
US stock futures traded close to flat on Thursday as investors weighed encouraging inflation data, another strong round of corporate earnings and ongoing geopolitical tensions in the Middle East. Market attention also turned to a busy schedule of economic releases and earnings reports that could shape sentiment for the remainder of the week. Futures pause…
-
Dow, S&P 500 and Nasdaq All Close Higher as Cooling Inflation Data Lifts Wall Street
Wall Street closed higher on Wednesday as investors welcomed another round of cooler-than-expected inflation data, sending all three major indexes into positive territory. The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite each notched gains after June producer price data came in softer than economists had forecast, adding to Tuesday’s encouraging consumer inflation reading.…
-
Glucotrack Completes Lōkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform
Glucotrack has completed its business combination with Lōkahi Therapeutics, transforming the company into a Lōkahi-controlled public platform focused on acquiring and advancing healthcare assets while retaining its continuous blood glucose monitoring business as a standalone subsidiary. Key Investor Takeaways Why GCTK Stock Is in Focus Glucotrack (NASDAQ:GCTK) announced the completion of its previously announced business…